Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Federal anti-kickback regulations prohibit pharmaceutical companies from offering copay assistance to patients with government insurance, including Medicare Part D, Medicaid, TRICARE, VA benefits, and other federal or state programs
With significant R&D resources now concentrated on clinical development, many pharmaceuticals are turning to CDMOs to achieve manufacturing efficiency and cost control at scale, shifting from traditional supplier relationships to long-term strategic partnerships
As levels stabilize between days two and six, side effects often improve
The pGBKT7-53 with pGADT7-T was used as a positive control, and pGBKT7-Lam with pGADT7-T was used as a negative control
US$ 26.85
US$ 29.92
US$ 27.86
US$ 29.75
